Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours
European Journal of Cancer2017Vol. 81, pp. 81–89
Citations Over Time
Antoine Hollebecque, Rastilav Bahleda, Laurence Faivre, Julien Adam, Vianney Poinsignon, Angélo Paci, Carlos Gomez‐Roca, Jean Christophe Théry, Marie‐Cécile Le Deley, Andréa Varga, A. Gazzah, E. Ileana, Myriam Gharib, Eric Angevin, K. Malekzadeh, Christophe Massard, Jean‐Charles Soria, Jean‐Philippe Spano
Related Papers
- → Temsirolimus for advanced renal cell carcinoma(2013)31 cited
- → Temsirolimus(2014)22 cited
- → Profile of temsirolimus in the treatment of advanced renal cell carcinoma(2010)10 cited
- → Schedule-dependent interaction between temsirolimus and cetuximab in head and neck cancer(2016)5 cited
- → Incidence of mucositis in patients with head and neck squamous cell carcinoma treated with radiotherapy plus cetuximab: a pilot study(2012)